Episode 14: Among the topics: ICD indications in 2023 - The diagnostic workup of cardiac amyloidosis

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

This episode covers:

Cardiology This Week: A concise summary of recent studies

Indications for ICD treatment: Current standards and new developments

The diagnostic workup of cardiac amyloidosis

Diagnostics Made Easy - Ventricular tachycardia

Host: Susanna Price

Guests: Davide Capodanno, Martha Grogan, Gerhard Hindricks and Emma Svennberg

Want to watch that episode?

Go to: https://esc365.escardio.org/event/1029

Disclaimer

This programme is intended for health care professionals only and is to be used for educational purposes.

The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

Declarations of interests

Stephan Achenbach, Gerhard Hindricks, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report.

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.

Martha Grogan has declared to have potential conflicts of interest to report: consultancy – Janssen, NovoNordisk. Research grant, or contract – Alnylam, Eidos, Janssen, Pfizer, NovoNordisk. Patent – Anumana. All Disclosures: no personal compensation, all funds to Mayo Clinic

Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.